154 related articles for article (PubMed ID: 31085008)
1. Correlated low IGF2BP1 and FOXM1 expression predicts a good prognosis in lung adenocarcinoma.
Huang H; Wang D; Guo W; Zhuang X; He Y
Pathol Res Pract; 2019 Jul; 215(7):152433. PubMed ID: 31085008
[TBL] [Abstract][Full Text] [Related]
2. CENPE promotes lung adenocarcinoma proliferation and is directly regulated by FOXM1.
Shan L; Zhao M; Lu Y; Ning H; Yang S; Song Y; Chai W; Shi X
Int J Oncol; 2019 Jul; 55(1):257-266. PubMed ID: 31115500
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
Liang SK; Hsu CC; Song HL; Huang YC; Kuo CW; Yao X; Li CC; Yang HC; Hung YL; Chao SY; Wu SC; Tsai FR; Chen JK; Liao WN; Cheng SC; Tsou TC; Wang IC
Oncogene; 2021 Jul; 40(30):4847-4858. PubMed ID: 34155349
[TBL] [Abstract][Full Text] [Related]
5. ALKBH5-m
Chao Y; Shang J; Ji W
Biochem Biophys Res Commun; 2020 Jan; 521(2):499-506. PubMed ID: 31677788
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma.
Kobayashi M; Nagashio R; Saito K; Aguilar-Bonavides C; Ryuge S; Katono K; Igawa S; Tsuchiya B; Jiang SX; Ichinoe M; Murakumo Y; Saegusa M; Satoh Y; Sato Y
Hum Pathol; 2018 Apr; 74():148-155. PubMed ID: 29320753
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
[TBL] [Abstract][Full Text] [Related]
9. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
[TBL] [Abstract][Full Text] [Related]
10. Circ-MMP2 (circ-0039411) induced by FOXM1 promotes the proliferation and migration of lung adenocarcinoma cells in vitro and in vivo.
Lv X; Huang H; Feng H; Wei Z
Cell Death Dis; 2020 Jun; 11(6):426. PubMed ID: 32513952
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
[TBL] [Abstract][Full Text] [Related]
12. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
[TBL] [Abstract][Full Text] [Related]
13. Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3β pathway in lung adenocarcinoma.
Wang Y; Piao J; Wang Q; Cui X; Meng Z; Jin T; Lin Z
Hum Pathol; 2019 Apr; 86():233-242. PubMed ID: 30496797
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas.
Milewski D; Balli D; Ustiyan V; Le T; Dienemann H; Warth A; Breuhahn K; Whitsett JA; Kalinichenko VV; Kalin TV
PLoS Genet; 2017 Dec; 13(12):e1007097. PubMed ID: 29267283
[TBL] [Abstract][Full Text] [Related]
15. Involvement of FoxM1 in non-small cell lung cancer recurrence.
Xu N; Wu SD; Wang H; Wang Q; Bai CX
Asian Pac J Cancer Prev; 2012; 13(9):4739-43. PubMed ID: 23167412
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma.
Koh YW; Han JH; Jeong D; Kim CJ
Pathol Res Pract; 2019 Jul; 215(7):152444. PubMed ID: 31079850
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Analyses Identify Differentially Expressed Proteins and Pathways Between Low-Risk and High-Risk Subtypes of Early-Stage Lung Adenocarcinoma and Their Prognostic Impacts.
Zhou J; Liu B; Li Z; Li Y; Chen X; Ma Y; Yan S; Yang X; Zhong L; Wu N
Mol Cell Proteomics; 2021; 20():100015. PubMed ID: 33508502
[TBL] [Abstract][Full Text] [Related]
18. High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma.
Niu R; Tang Y; Xi Y; Jiang D
J Surg Res; 2020 Jun; 250():216-223. PubMed ID: 32092599
[TBL] [Abstract][Full Text] [Related]
19. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
Su J; Wu S; Wu H; Li L; Guo T
Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
[TBL] [Abstract][Full Text] [Related]
20. Guanylate-binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients.
Wan Q; Qu J; Li L; Gao F
J Clin Lab Anal; 2021 Feb; 35(2):e23610. PubMed ID: 33301214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
